MedTrace Logo

Transfusion Rates in Total Hip Replacement Before/After the Implementation of a Patient Blood Management Program.

NCT04398238 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2023-05-30

No results posted yet for this study

Summary

Retrospective observational study: impact of a peri-operative patient blood management program (PBM) on transfusion rates of patients undergoing elective hip replacement.

Conditions

  • Anemia (Diagnosis)
  • Iron-deficiency
  • Transfusion
  • Arthroplasty

Interventions

COMBINATION_PRODUCT

evaluation by transfusion medicine specialist

screening for anemia causes and treatment: iron/folate/vitamin B12 supplementation, Erythropoietin administration if indicated

Sponsors & Collaborators

  • Istituto Ortopedico Rizzoli

    lead OTHER

Principal Investigators

  • Stefano Bonarelli, MD · Istituto Ortopedico Rizzoli

  • Sandra Giannone, MD · Istituto Ortopedico Rizzoli

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2022-11-25
Completion
2023-04-04

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04398238 on ClinicalTrials.gov